Annovis Bio, Inc.ANVSNYSE
Loading
EBITDA Over TimeContracting
Percentile Rank13
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$-29.52M
↓ 87% vs avg
Percentile
P13
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
$-15.78M
Historical baseline
PeriodValueYoY Change
TTM$-29.52M-10.6%
2024$-26.69M+40.7%
2023$-45.03M-76.5%
2022$-25.51M-75.9%
2021$-14.50M-
2020$0.00+100.0%
2019$-791000.00-1198584.8%
2018$66.00-21.4%
2017$84.00-